Stefan Arnold, Head of Business Development for Asia, talks about his pivotal role in this strategically important region and how it reflects the LTS approach of ‘think global, act local’.

There are three Ps that provide structure to the LTS business in North America. They have driven our consistent success over decades, and they will continue to drive our growth in the future.

For many people the pandemic has been a catalyst for some defining decisions about what their future purpose in life should look like. A sense of purpose has always been important to both individuals and organisations, however, now more than ever, it feels like a fundamental priority.

Patient first, patient centricity, better patient outcomes, greater patient adherence. Terms that are a daily part of the industry vocabulary as pharmaceutical companies and their partners around the world work tirelessly to improve the lives of patients.

At LTS, we are passionate about efficiency. We are continually challenging ourselves to employ resources as effectively as possible while maintaining the highest standards of safety and product quality expected by our pharmaceutical partners. From this philosophy, the IM Fluss project was born, with the aim of optimizing the flow of information and materials in our production facilities.